Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna    AET

AETNA (AET)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Aetna Ready For 'Dual Eligibles' Despite Commercial Focus - CFO

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/19/2012 | 09:55pm CET
   By Jon Kamp 
   Of  
 

Aetna Inc. (>> Aetna Inc.) believes it can ably serve health-challenged patients covered by both Medicare and Medicaid, even though the company doesn't have a major stake in those markets.

Additionally, the commercially-focused health insurer doesn't need acquisitions to win business for "dual eligible" patients, according to Chief Financial Officer Joseph Zubretsky. Some of Aetna's big competitors have recently made deals with an eye on dual patients, and Aetna has faced questions about whether it has the right make-up for the market.

"I do believe we'll have the platforms built to be able to respond to this opportunity," Zubretsky said, speaking during an interview at Aetna's Hartford headquarters.

The market has significant potential, but will build over several years, giving Aetna time to grow its businesses from within, Zubretsky said. Meantime, Aetna has the capabilities within these businesses to address the kind of complex health problems dual patients often present, he said.

Dual patients, who represent a potential $300 billion market for health insurers, have become a hot topic as states and the federal government look for ways to better coordinate care and save money. These patients tend to rack up high costs due to their health challenges. A handful of states could have programs for covering dual patients up and running next year, and the market is expected to continue growing in subsequent years.

Managed-care companies could be big beneficiaries, but questions abound about which firms are best positioned to win state-by-state contracts. Analysts view Medicaid-focused insurers such as Molina Healthcare Inc. (>> Molina Healthcare, Inc.) and Centene Corp. (>> Centene Corp) as potential winners, and bigger insurers such as UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) and WellPoint Inc. (WLP) are also expected to compete based on their presence in both the Medicaid and Medicare markets.

Aetna has modest stakes in markets for government-based plans. At the end of last year, roughly 90% of Aetna's 18.5 million medical members were on commercial health plan, which are typically plans provided through employers.

Citigroup analyst Carl McDonald recently said Aetna's valuation has been hurt by "the company's lack of government exposure". Still, Aetna shares are up 33% over the last year, helped by patients keeping a lid on health costs after the recession.

Competitors including UnitedHealth, WellPoint and Cigna Inc. (CI) have all recently made Medicare-focused acquisitions that could improve their chances in the duals market. Aetna has been wary of paying too much, however, and feels there is time to build up its own businesses.

"The opportunity has been reflected in certain managed care valuations long before the revenue is ever going to show up," Zubretsky said. "This is not a cataclysmic event where $300 billion dollars is going to race into the market inside of 12 months. It's going to happen in a phased approach."

Aetna Chief Executive Mark Bertolini has talked about the company's ability to grow its Medicare business by keeping commercial members on Aetna plans when they switch over to Medicare. There are about 1.2 million Medicare-eligible members in the company's commercial membership. He also noted Aetna has more than doubled revenue in its Medicaid business since acquiring it in 2007.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; [email protected]

Valeurs citées dans l'article
ChangeLast1st jan.
AETNA 0.26% 176.19 Delayed Quote.-1.31%
CENTENE CORPORATION 0.09% 100.4464 Delayed Quote.-0.61%
MOLINA HEALTHCARE, INC. 1.36% 72.06 Delayed Quote.-6.29%
UNITEDHEALTH GROUP 1.34% 228 Delayed Quote.2.81%
WELLPOINT INC 0.69% 129.16 End-of-day quote.39.80%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA
02/21AETNA : Announces New Accountable Care Agreement in Georgia with Sequent Health ..
PU
02/21Albertsons to buy Rite Aid as Amazon threat looms
RE
02/20AETNA INC /PA/ : Change in Directors or Principal Officers, Financial Statements..
AQ
02/19AETNA : Companies Pay Workers to Get Savvier With Money
DJ
02/15AETNA : Trademark Application for "INFORMED HEALTH" Filed by Aetna
AQ
02/15AETNA : Opens Support Lines to the Public Following Broward County School Shooti..
BU
02/14AETNA : Disputes Report That Medical Director Ignored Patients' Records
AQ
02/13RITE AID : Chronic pain patients report struggles under tighter opioid regulatio..
AQ
02/09AETNA INC /PA/ : Other Events (form 8-K)
AQ
02/09MEDICA : Wellmark to return to Iowa exchange, sell ACA-compliant plans
AQ
More news
News from SeekingAlpha
08:40aTracking Dan Loeb's Third Point Portfolio - Q4 2017 Update 
02/20HHS debuts new rule allowing increased access to short-term insurance plans 
02/20Healthcare Innovation Or Exacerbating The Crisis? 
02/18Tracking George Soros's Portfolio - Q4 2017 Update 
02/14Aetna says inflammatory CNN story untrue 
Financials ($)
Sales 2018 61 391 M
EBIT 2018 4 904 M
Net income 2018 3 382 M
Debt 2018 -
Yield 2018 1,06%
P/E ratio 2018 17,06
P/E ratio 2019 15,21
Capi. / Sales 2018 0,94x
Capi. / Sales 2019 0,89x
Capitalization 57 467 M
Chart AETNA
Duration : Period :
Aetna Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Technical analysis trends AETNA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 206 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
AETNA-1.31%57 467
UNITEDHEALTH GROUP2.81%217 850
ANTHEM INC3.20%59 576
CIGNA-5.17%47 251
HUMANA7.76%38 055
CENTENE CORPORATION-0.61%17 291